Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Shariat

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
ESMO Open|October 8, 2022
The current role of precision surgery in oligometastatic prostate cancerM von Deimling, P Rajwa, D Tilki, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 6, 2014
Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancerA Larcher, M Sun, J Schiffmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upT Powles, J Bellmunt, E Comperat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 13, 2008
Partin Tables cannot accurately predict the pathological stage at radical prostatectomyN Bhojani, S Ahyai, M Graefen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2024
ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinomaT Powles, J Bellmunt, E Comperat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 2, 2016
Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experienceM Moschini, R J Karnes, V Sharma, et al.
British Journal of Cancer|August 29, 2013
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladderE Xylinas, M Kent, L Kluth, et al.
Prostate Cancer and Prostatic Diseases|January 27, 2016
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomyS Sevcenco, R Mathieu, P Baltzer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 11, 2019
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival OutcomesF A Mistretta, S-J Cyr, C Palumbo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2017
<sup>68</sup>Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy - diagnostic performance and impact on therapeutic decision-makingB Grubmüller, P Baltzer, D D'Andrea, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
ESMO Open|October 8, 2022
The current role of precision surgery in oligometastatic prostate cancerM von Deimling, P Rajwa, D Tilki, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 6, 2014
Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancerA Larcher, M Sun, J Schiffmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upT Powles, J Bellmunt, E Comperat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 13, 2008
Partin Tables cannot accurately predict the pathological stage at radical prostatectomyN Bhojani, S Ahyai, M Graefen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2024
ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinomaT Powles, J Bellmunt, E Comperat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 2, 2016
Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experienceM Moschini, R J Karnes, V Sharma, et al.
British Journal of Cancer|August 29, 2013
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladderE Xylinas, M Kent, L Kluth, et al.
Prostate Cancer and Prostatic Diseases|January 27, 2016
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomyS Sevcenco, R Mathieu, P Baltzer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 11, 2019
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival OutcomesF A Mistretta, S-J Cyr, C Palumbo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2017
<sup>68</sup>Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy - diagnostic performance and impact on therapeutic decision-makingB Grubmüller, P Baltzer, D D'Andrea, et al.
Pageof 10